← See Pat Ryan's full record
H.R.6323 Iran Counterterrorism Act
Requires Iran to cease all support for terrorism before sanctions waivers can be granted (118th Congress)
View on Congress.govLegal & Constitutional Grounding
Unverifiable preconditions eliminate diplomacy; 96% of drug shortages were technically sanctions-exempt but blocked by overcompliance.
IEEPA, 50 U.S.C. § 1701 et seq. — presidential sanctions authority constrained by impossible-to-verify preconditions
- CISADA, 22 U.S.C. § 8501 et seq.
- HRW 'Maximum Pressure' (Oct. 2019) — bank overcompliance creates de facto embargo on humanitarian goods despite exemptions
- WHO EMRO — 13 of 26 NCD medicines with reduced availability; 96% of shortage drugs should have been exempt from sanctions (Setayesh & Mackey 2016)
- Lancet (2025) — Swiss pharma company fined $17M by US for delivering thalassemia medicine to Iran; counterfeit medicines flooded market
- CEPR/Rodriguez (2023) — review of 32 studies: sanctions lead to accumulated GDP per capita declines reaching 26% (comparable to Great Depression)
Iran Counterterrorism Act — imposes conditions requiring Iran to cease all terrorism support before waivers. Preconditions that are impossible to verify effectively eliminate the president's ability to pursue diplomatic agreements.